Canadian firm Jamp Pharma Corporation has established a Centre of Excellence, its first such outside Canada, in Genome Valley, the well known Life Sciences cluster on the outskirts of Hyderabad.
Poised to be one of the key drivers of the company’s growth plan, the facility will contribute to about 25% of Jamp’s total product pipeline in phase-1 itself, Industries and IT Minister K. T. Rama Rao’s office said on the occasion of commissioning the CoE on Tuesday.
Of the proposed total investment of about ₹250 crore and creation of jobs for 200 people, the company has invested around ₹100 crore in the first phase and created employment for around 80 people. It plans to implement other phases over the next two years. A release from the Minister’s office said the CoE is designed to cater to solid oral dosage form, powders, topicals, nasal delivery and liquid oral pharmaceutical products for regulated markets. The company is working on another project — a manufacturing facility for nasal spray which is intended to be completed in a year.
